Davidson Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-73
Closed -$16K 156
2022
Q3
$16K Sell
73
-5,683
-99% -$1.38M 0.01% 39
2022
Q2
$1.4M Sell
5,756
-721
-11% -$177K 0.66% 10
2022
Q1
$1.57M Buy
6,477
+2,405
+59% +$553K 0.58% 12
2021
Q4
$916K Sell
4,072
-1,297
-24% -$274K 0.5% 66
2021
Q3
$1.14M Buy
5,369
+223
+4% +$51.3K 0.58% 62
2021
Q2
$1.25M Buy
5,146
+400
+8% +$98.4K 0.6% 41
2021
Q1
$1.18M Sell
4,746
-161
-3% -$38.4K 0.62% 37
2020
Q4
$1.13M Buy
4,907
+3,349
+215% +$772K 0.63% 27
2020
Q3
$396K Buy
+1,558
New +$386K 0.25% 54

Other funds holding AMGN

Davidson Capital Management's AMGN Position: Q4 2022 in Review

Davidson Capital Management sold out of Amgen (AMGN) in Q4 2022, closing a stake of 73 shares — an estimated $16K sold.

Davidson Capital Management first reported a position in AMGN in Q3 2020 and held it in 9 quarters. The position peaked at $1.57M in Q1 2022. 2,502 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Davidson Capital Management reported no remaining Amgen position as of Q4 2022 after selling out during the quarter.
  • Davidson Capital Management sold 73 Amgen shares in Q4 2022, an estimated $16K.
  • Davidson Capital Management first reported a position in Amgen in Q3 2020 and held it in 9 quarters.
  • Davidson Capital Management's Amgen position peaked at $1.57M in Q1 2022.
  • 2,502 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Davidson Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.